HIGHLIGHTS
- who: Ikhwan Rinaldi from the University of Messina, Italy have published the research: Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis, in the Journal: (JOURNAL) of March/15,/2022
- what: The analysis of Perry et_al showed that there were no statistically COVID-19 has been the focus of researchers worldwide for the last 2 years. In this systematic review, the authors identified 8 out of 15 studies reporting a seroconversion rate after administering the first dose of the COVID-19 mRNA_vaccine (RR 0.30 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.